Figure 3.
IRs for malignancies excluding NMSC (A) and (B) NMSC over time for all tofacitinib doses. IR, incidence rate; NMSC, non-melanoma skin cancer.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.